Skye Bioscience, Inc. Common Stock (SKYE) — Cash Flow Quality Index
Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Quality Index of 0.00x as of December 2025. Operating cash flow of $-9.77 Million is below net income of $11.08 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Skye Bioscience, Inc. Common Stock (SKYE) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Skye Bioscience, Inc. Common Stock Cash Flow Quality Index (2012–2019)
Historical Cash Flow Quality Index for Skye Bioscience, Inc. Common Stock across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Skye Bioscience, Inc. Common Stock total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Skye Bioscience, Inc. Common Stock (2012–2019)
Year-by-year earnings quality comparison for Skye Bioscience, Inc. Common Stock. For live market cap and the full company financial profile, see Skye Bioscience, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -5.73x | $-6.03 Million | $1.05 Million | ▼ -1440.3% |
| 2012 | 0.43x | $1.93K | $4.51K | — |